HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
C Q Li Selected Research
C Q Li Research Topics
Disease
3
Neoplasms (Cancer)
12/2023 - 01/2013
2
Carcinogenesis
04/2001 - 01/2001
1
Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2020
1
Mucocele
08/2020
1
Abscess
08/2020
1
Acquired Immunodeficiency Syndrome (AIDS)
08/2020
1
Neoplasms, Cystic, Mucinous, and Serous
08/2020
1
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/2020
1
Appendicitis
08/2020
1
Autoimmune Diseases (Autoimmune Disease)
08/2020
1
Hematologic Diseases (Blood Diseases)
08/2020
1
Afibrinogenemia (Fibrinogen Deficiency)
10/2018
1
Postpartum Hemorrhage
10/2018
1
Snoring
10/2017
1
Cough
10/2017
1
Asthma (Bronchial Asthma)
10/2017
1
Respiratory Tract Infections (Respiratory Tract Infection)
10/2017
1
Laryngismus (Laryngospasm)
10/2017
1
Bronchial Spasm
10/2017
1
Endometriosis
01/2016
1
Hepatitis A (Hepatitis, Infectious)
12/2015
1
Diabetes Mellitus
07/2015
1
Hemophilia A (Haemophilia)
07/2015
1
Hemorrhage
07/2015
1
Stomach Neoplasms (Stomach Cancer)
01/2013
1
Adenoma (Adenomas)
02/2011
1
Polyps
02/2011
1
Colonic Polyps
02/2011
1
Esophageal Squamous Cell Carcinoma
02/2009
1
Thrombocytopenia (Thrombopenia)
07/2001
1
Pathologic Processes
07/2001
1
platelet type Von Willebrand disease
07/2001
1
Bernard-Soulier Syndrome (Giant Platelet Syndrome)
07/2001
1
Vascular System Injuries
07/2001
1
Duodenal Ulcer (Curling's Ulcer)
04/2001
1
Gastritis
04/2001
1
Infections
04/2001
1
Lung Neoplasms (Lung Cancer)
01/2001
1
Thrombosis (Thrombus)
07/2000
1
Vitiligo
06/2000
1
Ischemia
03/2000
1
Hypoxia (Hypoxemia)
03/2000
1
Inflammation (Inflammations)
01/2000
Drug/Important Bio-Agent (IBA)
3
Proteins (Proteins, Gene)
FDA Link
10/2018 - 01/2001
3
Antibodies
IBA
12/2015 - 01/2001
2
Fibrinogen (Factor I)
FDA Link
10/2018 - 01/2001
2
3-nitrotyrosine
IBA
04/2001 - 01/2001
2
Oxidants (Oxidizing Agents)
IBA
01/2001 - 03/2000
1
Monoclonal Antibodies
IBA
12/2023
1
tislelizumab
IBA
12/2023
1
Anti-Bacterial Agents (Antibiotics)
IBA
08/2020
1
Tobacco Smoke Pollution (Passive Smoking)
IBA
10/2017
1
Oxygen (Dioxygen)
IBA
10/2017
1
Viral RNA
IBA
12/2015
1
Cholesterol
IBA
07/2015
1
Factor VIII (Coagulation Factor VIII)
IBA
07/2015
1
MG7 monoclonal antibody
IBA
01/2013
1
Antigens
IBA
01/2013
1
Fluorescent Dyes (Fluorescent Probes)
IBA
01/2013
1
Fluorescein (Funduscein)
FDA Link
Generic
02/2011
1
Thrombin
FDA Link
07/2001
1
Platelet Membrane Glycoproteins
IBA
07/2001
1
Plasminogen
IBA
01/2001
1
DNA (Deoxyribonucleic Acid)
IBA
01/2001
1
Smoke
IBA
01/2001
1
Ceruloplasmin (Ferroxidase)
IBA
01/2001
1
Blood Proteins (Serum Proteins)
IBA
01/2001
1
Transferrin (beta 2 Transferrin)
IBA
01/2001
1
Reactive Nitrogen Species
IBA
01/2001
1
Integrins
IBA
07/2000
1
halometasone
IBA
06/2000
1
Adenosine (Adenocard)
FDA Link
Generic
03/2000
1
Antioxidants
IBA
03/2000
1
Interleukin-8 (Interleukin 8)
IBA
01/2000
Therapy/Procedure
3
Lasers (Laser)
01/2013 - 02/2009
1
Overlapping Surgery
08/2020
1
Appendectomy
08/2020
1
Therapeutics
08/2020
1
Epidural Anesthesia
10/2018
1
Operative Surgical Procedures
10/2018
1
Anesthesia
10/2017
1
Perioperative Period
10/2017
1
General Anesthesia
10/2017
1
Cesarean Section (Caesarean Section)
01/2016
1
Blood Transfusion (Blood Transfusions)
12/2015
1
Endoscopes
02/2011